194 related articles for article (PubMed ID: 29173108)
1. Effects of image congruency on persuasiveness and recall in direct-to-consumer prescription drug advertising.
Kiernicki K; Helme DW
Health Mark Q; 2017; 34(4):284-301. PubMed ID: 29173108
[TBL] [Abstract][Full Text] [Related]
2. Correction of misleading information in prescription drug television advertising: The roles of advertisement similarity and time delay.
Aikin KJ; Southwell BG; Paquin RS; Rupert DJ; O'Donoghue AC; Betts KR; Lee PK
Res Social Adm Pharm; 2017; 13(2):378-388. PubMed ID: 27178746
[TBL] [Abstract][Full Text] [Related]
3. Visual presentations of efficacy data in direct-to-consumer prescription drug print and television advertisements: A randomized study.
Sullivan HW; O'Donoghue AC; Aikin KJ; Chowdhury D; Moultrie RR; Rupert DJ
Patient Educ Couns; 2016 May; 99(5):790-9. PubMed ID: 26749356
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Including Quantitative Information on Multiple Endpoints in Direct-to-Consumer Prescription Drug Television Advertisements.
Sullivan HW; O'Donoghue AC; Lynch M; Johnson M; Davis C; Rupert DJ
Med Decis Making; 2019 Nov; 39(8):975-985. PubMed ID: 31583947
[No Abstract] [Full Text] [Related]
5. Effects of comparative claims in prescription drug direct-to-consumer advertising on consumer perceptions and recall.
O'Donoghue AC; Williams PA; Sullivan HW; Boudewyns V; Squire C; Willoughby JF
Soc Sci Med; 2014 Nov; 120():1-11. PubMed ID: 25194471
[TBL] [Abstract][Full Text] [Related]
6. Serious and actionable risks, plus disclosure: Investigating an alternative approach for presenting risk information in prescription drug television advertisements.
Betts KR; Boudewyns V; Aikin KJ; Squire C; Dolina S; Hayes JJ; Southwell BG
Res Social Adm Pharm; 2018 Oct; 14(10):951-963. PubMed ID: 28844621
[TBL] [Abstract][Full Text] [Related]
7. Effects of risk disclosure prominence in direct-to-consumer advertising (DTCA) of prescription drugs: An integrative cognitive process model.
Ju I; Park JS
Health Mark Q; 2018; 35(1):32-46. PubMed ID: 29608136
[TBL] [Abstract][Full Text] [Related]
8. Selling Health to the Distracted: Consumer Responses to Source Credibility and Ad Appeal Type in a Direct-to-Consumer Advertisement.
Lemanski JL; Villegas J
Health Mark Q; 2015; 32(3):217-33. PubMed ID: 26368298
[TBL] [Abstract][Full Text] [Related]
9. Fair Balance and Adequate Provision in Direct-to-Consumer Prescription Drug Online Banner Advertisements: A Content Analysis.
Adams C
J Med Internet Res; 2016 Feb; 18(2):e33. PubMed ID: 26892749
[TBL] [Abstract][Full Text] [Related]
10. Individual- and Ad-Level Predictors of Perceptions of Serious and Actionable Risks in Direct-to-Consumer Prescription Drug TV Advertising.
Aikin KJ; Boudewyns V; Betts KR; Southwell BG; Williams P
J Health Commun; 2019; 24(5):536-546. PubMed ID: 31253071
[TBL] [Abstract][Full Text] [Related]
11. Impact of Animated Spokes-Characters in Print Direct-to-Consumer Prescription Drug Advertising: An Elaboration Likelihood Model Approach.
Bhutada NS; Rollins BL; Perri M
Health Commun; 2017 Apr; 32(4):391-400. PubMed ID: 27315337
[TBL] [Abstract][Full Text] [Related]
12. Optimistic bias, advertising skepticism, and consumer intentions for seeking information about the health risks of prescription medicine.
Park JS; Ahn HA; Haley EJ
Health Mark Q; 2017; 34(2):81-96. PubMed ID: 28590885
[TBL] [Abstract][Full Text] [Related]
13. Enhancing the educational value of direct-to-consumer advertising of prescription drugs.
Hwang MJ; Young HN
J Am Pharm Assoc (2003); 2017; 57(5):571-578. PubMed ID: 28676435
[TBL] [Abstract][Full Text] [Related]
14. Maintaining a Fair Balance? Narrative and Non-Narrative Strategies in Televised Direct-to-Consumer Advertisements for Prescription Drugs Aired in the United States, 2003-2016.
Liu J; Avery RJ; Kim JJ; Niederdeppe J
J Health Commun; 2022 Mar; 27(3):183-191. PubMed ID: 35593131
[TBL] [Abstract][Full Text] [Related]
15. Placement and Format of Risk Information on Direct-to-Consumer Prescription Drug Websites.
Sullivan HW; O'Donoghue AC; Rupert DJ; Willoughby JF; Aikin KJ
J Health Commun; 2017 Feb; 22(2):171-181. PubMed ID: 28129069
[TBL] [Abstract][Full Text] [Related]
16. Visual images of prescription drug benefits in direct-to-consumer television advertisements.
Sullivan HW; O'Donoghue AC; Lynch M; Johnson M; Davis C; Amoozegar JB; Rupert DJ
Patient Educ Couns; 2021 Sep; 104(9):2240-2249. PubMed ID: 33618970
[TBL] [Abstract][Full Text] [Related]
17. Effect of presentation modality in direct-to-consumer (DTC) prescription drug television advertisements.
Wogalter MS; Shaver EF; Kalsher MJ
Appl Ergon; 2014 Sep; 45(5):1330-6. PubMed ID: 24377979
[TBL] [Abstract][Full Text] [Related]
18. Communicating efficacy information based on composite scores in direct-to-consumer prescription drug advertising.
Williams PA; O'Donoghue AC; Sullivan HW; Willoughby JF; Squire C; Parvanta S; Betts KR
Patient Educ Couns; 2016 Apr; 99(4):583-590. PubMed ID: 26589655
[TBL] [Abstract][Full Text] [Related]
19. Direct-to-Consumer Broadcast Advertisements for Pharmaceuticals: Off-Label Promotion and Adherence to FDA Guidelines.
Klara K; Kim J; Ross JS
J Gen Intern Med; 2018 May; 33(5):651-658. PubMed ID: 29484575
[TBL] [Abstract][Full Text] [Related]
20. Asking a doctor versus referring to the Internet: A comparison study on consumers' reactions to DTC (direct-to-consumer) prescription drug advertising.
Jiang P
Health Mark Q; 2018; 35(3):209-226. PubMed ID: 30551729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
